KYNB KYNTRA BIO, INC.
Nasdaq · SEC CIK 921299 · EDGAR
- Bought, last 12 months
- $33.8K 3 purchases by 1 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 176 since 2021-07-08, latest 2026-09-09 20:42
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Wettig Thane | CEO, Dir | $33.8K | — |
| DeLucia David | CFO | — | — |
Transactions 174
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-09 20:42 | 2026-09-06 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $8.55 | -209 | 26.8K | -0.8% | -$1,787 | |
| 2026-09-09 20:41 | 2026-09-06 | KYNB | DeLucia David | CFO | F - Tax | $8.55 | -22 | 4,355 | -0.5% | -$188.10 | |
| 2026-06-09 17:46 | 2026-06-06 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $6.71 | -198 | 27.0K | -0.7% | -$1,329 | |
| 2026-06-09 17:44 | 2026-06-06 | KYNB | DeLucia David | CFO | F - Tax | $6.71 | -52 | 4,377 | -1% | -$348.92 | |
| A | 2026-05-19 15:08 | 2026-05-14 | KYNB | Wettig Thane | CEO, Dir | P - Purchase | $7.09 | +2,800 | 27.2K | +11% | +$19.9K |
| 2026-05-18 08:00 | 2026-05-14 | KYNB | Wettig Thane | CEO, Dir | P - Purchase | $7.09 | -2,800 | 27.2K | -9% | -$19.9K | |
| 2026-03-10 | 2026-03-06 | KYNB | DeLucia David | CFO | F - Tax | $6.84 | -60 | 4,429 | -1% | -$410.40 | |
| 2026-03-10 | 2026-03-06 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $6.84 | -277 | 24.4K | -1% | -$1,895 | |
| 2025-12-09 | 2025-12-06 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $8.42 | -259 | 24.7K | -1% | -$2,181 | |
| 2025-12-09 | 2025-12-06 | KYNB | DeLucia David | CFO | F - Tax | $8.42 | -52 | 4,489 | -1% | -$437.84 | |
| M | 2025-11-17 | 2025-11-13+ | KYNB | Wettig Thane | CEO, Dir | P - Purchase | $9.12 | +3,700 | 24.9K | +17% | +$33.8K |
| M | 2025-09-09 | 2025-06-06+ | KYNB | Wettig Thane | CEO, Dir | F - Tax | $9.97 | -494 | 21.2K | -2% | -$4,927 |
| M | 2025-09-09 | 2025-06-06+ | KYNB | DeLucia David | CFO | F - Tax | $10.01 | -104 | 4,594 | -2% | -$1,041 |
| I | 2025-07-02 | 2025-06-30 | KYNB | Schoeneck James A | Dir | P - Purchase | $5.07 | +23.6K | 39.7K | +146% | +$119.5K |
| 2025-03-25 | 2025-03-24 | KYNB | Wettig Thane | CEO, Dir | P - Purchase | $0.35 | +145.0K | 543.3K | +36% | +$50.8K | |
| MI | 2025-03-24 | 2025-03-20+ | KYNB | Schoeneck James A | Dir | P - Purchase | $0.3483 | +300.0K | 373.7K | +407% | +$104.5K |
| 2025-03-07 | 2025-03-06 | KYNB | Wettig Thane | CEO, Dir | A - Grant | $0.00 | +781 | 398.7K | +0.2% | $0 | |
| M | 2025-03-07 | 2025-03-06 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $0.39 | -22.4K | 397.9K | -5% | -$8,738 |
| 2025-03-07 | 2025-03-06 | KYNB | Chung Christine | SVP, CHINA Ops | A - Grant | $0.00 | +781 | 295.3K | +0.3% | $0 | |
| M | 2025-03-07 | 2025-03-06 | KYNB | Chung Christine | SVP, CHINA Ops | F - Tax | $0.39 | -7,430 | 294.5K | -2% | -$2,898 |
| 2025-03-07 | 2025-03-06 | KYNB | DeLucia David | CFO | F - Tax | $0.39 | -2,325 | 116.1K | -2% | -$906.75 | |
| 2024-12-09 | 2024-12-06 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $0.34 | -2,363 | 420.0K | -0.6% | -$803.42 | |
| 2024-12-09 | 2024-12-06 | KYNB | Chung Christine | SVP, CHINA Ops | F - Tax | $0.34 | -2,792 | 301.6K | -0.9% | -$949.28 | |
| M | 2024-12-09 | 2024-12-06+ | KYNB | Graham Juan | CFO | F - Tax | $0.34 | -2,512 | 165.9K | -1% | -$854.08 |
| 2024-09-09 | 2024-09-06 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $0.39 | -2,363 | 422.3K | -0.6% | -$921.57 | |
| M | 2024-09-09 | 2024-09-06+ | KYNB | Graham Juan | CFO | F - Tax | $0.39 | -17.1K | 168.4K | -9% | -$6,675 |
| 2024-09-09 | 2024-09-06 | KYNB | Chung Christine | SVP, CHINA Ops | F - Tax | $0.39 | -17.4K | 304.3K | -5% | -$6,784 | |
| 2024-08-05 | 2024-08-01 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $0.47 | -20.8K | 424.7K | -5% | -$9,795 | |
| 2024-06-25 | 2024-06-22 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $1.13 | -782 | 445.5K | -0.2% | -$883.66 | |
| 2024-06-13 | 2024-06-12 | KYNB | Adib Deyaa | Chief Medical Off | P - Purchase | $1.17 | +22.1K | 82.1K | +37% | +$25.9K | |
| M | 2024-06-10 | 2024-06-06+ | KYNB | Graham Juan | CFO | F - Tax | $1.18 | -19.0K | 185.7K | -9% | -$22.5K |
| 2024-06-07 | 2024-06-06 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $1.19 | -2,255 | 446.3K | -0.5% | -$2,683 | |
| 2024-06-07 | 2024-06-06 | KYNB | Chung Christine | SVP, CHINA Ops | F - Tax | $1.19 | -19.3K | 321.7K | -6% | -$23.0K | |
| 2024-05-02 | 2024-05-01 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $1.17 | -20.8K | 448.6K | -4% | -$24.4K | |
| 2024-03-25 | 2024-03-22 | KYNB | Wettig Thane | CEO, Dir | F - Tax | $2.58 | -782 | 469.4K | -0.2% | -$2,018 | |
| 2024-03-11 | 2024-03-07 | KYNB | Wettig Thane | CEO | P - Purchase | $1.91 | +50.0K | 470.2K | +12% | +$95.5K | |
| 2024-03-08 | 2024-03-06 | KYNB | Chung Christine | SVP, CHINA Ops | A - Grant | $0.00 | +781 | 341.4K | +0.2% | $0 | |
| M | 2024-03-08 | 2024-03-06 | KYNB | Chung Christine | SVP, CHINA Ops | F - Tax | $1.87 | -23.6K | 341.0K | -6% | -$44.1K |
| M | 2024-03-08 | 2024-03-06+ | KYNB | Graham Juan | CFO | F - Tax | $1.87 | -21.9K | 204.3K | -10% | -$40.9K |
| 2024-03-08 | 2024-03-06 | KYNB | Graham Juan | CFO | A - Grant | $0.00 | +781 | 205.1K | +0.4% | $0 | |
| M | 2024-03-08 | 2024-03-06 | KYNB | Wettig Thane | CEO | F - Tax | $1.87 | -4,535 | 419.7K | -1% | -$8,480 |
| 2024-03-08 | 2024-03-06 | KYNB | Wettig Thane | CEO | A - Grant | $0.00 | +781 | 420.5K | +0.2% | $0 | |
| D | 2024-02-23 | 2024-02-21 | KYNB | Graham Juan | CFO | A - Grant | $0.00 | +52.0K | 224.6K | +30% | $0 |
| D | 2024-02-23 | 2024-02-21 | KYNB | Wettig Thane | CEO | A - Grant | $0.00 | +166.0K | 423.9K | +64% | $0 |
| D | 2024-02-23 | 2024-02-21 | KYNB | Chung Christine | SVP, CHINA Ops | A - Grant | $0.00 | +29.0K | 363.8K | +9% | $0 |
| 2024-02-05 | 2024-02-01 | KYNB | Wettig Thane | CEO | F - Tax | $2.37 | -23.5K | 257.9K | -8% | -$55.7K | |
| 2023-12-26 | 2023-12-22 | KYNB | Wettig Thane | CEO | F - Tax | $0.76 | -819 | 281.4K | -0.3% | -$622.44 | |
| 2023-12-11 | 2023-12-06 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $0.58 | -18.2K | 334.8K | -5% | -$10.5K | |
| 2023-12-11 | 2023-12-06 | KYNB | Wettig Thane | CEO | F - Tax | $0.58 | -1,680 | 282.2K | -0.6% | -$974.40 | |
| M | 2023-12-11 | 2023-12-06+ | KYNB | Graham Juan | CFO | F - Tax | $0.5826 | -16.7K | 172.6K | -9% | -$9,705 |
| 2023-11-03 | 2023-11-01 | KYNB | Wettig Thane | CEO | F - Tax | $0.55 | -21.8K | 283.9K | -7% | -$12.0K | |
| 2023-09-25 | 2023-09-22 | KYNB | Wettig Thane | Interim CEO | F - Tax | $0.79 | -819 | 305.8K | -0.3% | -$647.01 | |
| 2023-09-08 | 2023-09-06 | KYNB | Wettig Thane | Interim CEO | F - Tax | $0.96 | -1,680 | 306.6K | -0.5% | -$1,613 | |
| M | 2023-09-08 | 2023-09-06+ | KYNB | Graham Juan | CFO | F - Tax | $0.9782 | -1,807 | 190.4K | -0.9% | -$1,768 |
| 2023-09-08 | 2023-09-06 | KYNB | Chung Christine | SVP, China Ops | F - Tax | $0.96 | -3,308 | 353.0K | -0.9% | -$3,176 | |
| 2023-09-08 | 2023-09-06 | KYNB | Eisner Mark | EVP, Chief Medical Off | F - Tax | $0.96 | -1,860 | 159.9K | -1% | -$1,786 | |
| 2023-09-06 | 2023-09-01 | KYNB | Eisner Mark | EVP, Chief Medical Off | F - Tax | $1.06 | -1,085 | 161.8K | -0.7% | -$1,150 | |
| 2023-09-06 | 2023-09-01 | KYNB | Henderson Jeffrey William | Dir | S - Sale | $1.03 | -2,000 | 28.9K | -6% | -$2,060 | |
| D | 2023-09-01 | 2023-08-30 | KYNB | Chung Christine | SVP, China Ops | A - Grant | $0.00 | +120.0K | 356.3K | +51% | $0 |
| D | 2023-09-01 | 2023-08-30 | KYNB | Graham Juan | CFO | A - Grant | $0.00 | +120.0K | 191.1K | +169% | $0 |
| D | 2023-08-09 | 2023-08-07 | KYNB | Wettig Thane | Chief Commercial Off | A - Grant | $0.00 | +200.0K | 308.3K | +185% | $0 |
| 2023-08-08 | 2023-08-04 | KYNB | Henderson Jeffrey William | Dir | S - Sale | $1.91 | -2,000 | 30.9K | -6% | -$3,820 | |
| 2023-07-13 | 2023-07-11 | KYNB | Henderson Jeffrey William | Dir | S - Sale | $2.69 | -2,000 | 32.9K | -6% | -$5,380 | |
| 2023-07-10 | 2023-07-07 | KYNB | Conterno Enrique A | CEO, Dir | S - Sale | $2.80 | -1,880 | 374.7K | -0.5% | -$5,264 | |
| 2023-06-26 | 2023-06-23 | KYNB | Wettig Thane | Chief Commercial Off | S - Sale | $16.53 | -791 | 108.3K | -0.7% | -$13.1K | |
| MA | 2023-06-22 | 2023-06-07 | KYNB | Wettig Thane | Chief Commercial Off | S - Sale | $17.04 | -1,758 | 109.1K | -2% | -$30.0K |
| M | 2023-06-15 | 2023-06-13+ | KYNB | Chung Christine | SVP, China Ops | S - Sale | $17.19 | -12.5K | 236.3K | -5% | -$214.9K |
| DM | 2023-06-09 | 2023-06-09 | KYNB | Brennan Aoife | Dir | S - Sale | $17.19 | -4,733 | 30.7K | -13% | -$81.4K |
| D | 2023-06-09 | 2023-06-07 | KYNB | Brennan Aoife | Dir | A - Grant | $0.00 | +8,289 | 32.7K | +34% | $0 |
| M | 2023-06-09 | 2023-06-07 | KYNB | Conterno Enrique A | CEO, Dir | S - Sale | $17.04 | -8,897 | 382.7K | -2% | -$151.6K |
| DM | 2023-06-09 | 2023-06-09 | KYNB | Blaug Suzanne | Dir | S - Sale | $17.20 | -8,520 | 29.6K | -22% | -$146.6K |
| D | 2023-06-09 | 2023-06-07 | KYNB | Blaug Suzanne | Dir | A - Grant | $0.00 | +8,289 | 38.1K | +28% | $0 |
| DM | 2023-06-09 | 2023-06-08 | KYNB | Henderson Jeffrey William | Dir | S - Sale | $17.46 | -7,000 | 34.9K | -17% | -$122.2K |
| D | 2023-06-09 | 2023-06-07 | KYNB | Henderson Jeffrey William | Dir | A - Grant | $0.00 | +8,289 | 41.9K | +25% | $0 |
| 2023-06-09 | 2023-06-07 | KYNB | Eisner Mark | EVP, Chief Medical Off | S - Sale | $17.04 | -2,042 | 162.9K | -1% | -$34.8K | |
| D | 2023-06-09 | 2023-06-07 | KYNB | Cravatt Benjamin | Dir | A - Grant | $0.00 | +8,289 | 32.7K | +34% | $0 |
| DM | 2023-06-09 | 2023-06-09 | KYNB | Cravatt Benjamin | Dir | S - Sale | $17.17 | -3,944 | 28.7K | -12% | -$67.7K |
| M | 2023-06-09 | 2023-06-07 | KYNB | Chung Christine | SVP, China Ops | S - Sale | $17.04 | -3,633 | 251.1K | -1% | -$61.9K |
| M | 2023-06-09 | 2023-06-07 | KYNB | Graham Juan | CFO | S - Sale | $16.99 | -1,785 | 71.8K | -2% | -$30.3K |
| D | 2023-06-09 | 2023-06-07 | KYNB | EDWARDS JEFFREY L | Dir | A - Grant | $0.00 | +8,289 | 41.9K | +25% | $0 |
| DM | 2023-06-09 | 2023-06-09 | KYNB | EDWARDS JEFFREY L | Dir | S - Sale | $17.19 | -7,889 | 38.6K | -17% | -$135.6K |
| DI | 2023-06-09 | 2023-06-07 | KYNB | Schoeneck James A | Dir | S - Sale | $18.03 | -7,100 | 73.7K | -9% | -$128.0K |
| D | 2023-06-09 | 2023-06-07 | KYNB | Schoeneck James A | Dir | A - Grant | $0.00 | +8,289 | 28.8K | +40% | $0 |
| D | 2023-06-09 | 2023-06-07 | KYNB | Lema Gerald | Dir | A - Grant | $0.00 | +8,289 | 28.8K | +40% | $0 |
| DM | 2023-06-09 | 2023-06-08 | KYNB | Ho Maykin | Dir | S - Sale | $17.44 | -8,520 | 37.7K | -18% | -$148.6K |
| D | 2023-06-09 | 2023-06-07 | KYNB | Ho Maykin | Dir | A - Grant | $0.00 | +8,289 | 40.0K | +26% | $0 |
| M | 2023-06-09 | 2023-06-07 | KYNB | Wettig Thane | Chief Commercial Off | S - Sale | $17.04 | -1,758 | 112.7K | -2% | -$30.0K |
| 2023-06-05 | 2023-06-02 | KYNB | Eisner Mark | EVP, Chief Medical Off | S - Sale | $18.83 | -1,090 | 164.9K | -0.7% | -$20.5K | |
| 2023-04-11 | 2023-04-10 | KYNB | Conterno Enrique A | CEO, Dir | S - Sale | $19.52 | -1,869 | 383.0K | -0.5% | -$36.5K | |
| 2023-04-06 | 2023-04-04 | KYNB | Eisner Mark | Chief Medical Off | S - Sale | $18.78 | -9,182 | 166.0K | -5% | -$172.4K | |
| 2023-04-06 | 2023-04-04 | KYNB | Chung Christine | SVP, China Ops | S - Sale | $18.78 | -6,590 | 252.5K | -3% | -$123.8K | |
| 2023-03-29 | 2023-03-20 | KYNB | Wettig Thane | Chief Commercial Off | G - Gift | $0.00 | -2,343 | 108.3K | -2% | $0 | |
| I | 2023-03-29 | 2023-03-20 | KYNB | Wettig Thane | Chief Commercial Off | G - Gift | $0.00 | +1,000 | 1,000 | New | $0 |
| 2023-03-24 | 2023-03-23 | KYNB | Wettig Thane | Chief Commercial Off | S - Sale | $18.71 | -905 | 110.7K | -0.8% | -$16.9K | |
| A | 2023-03-23 | 2023-03-10 | KYNB | Conterno Enrique A | CEO, Dir | S - Sale | $20.20 | -19.5K | 384.9K | -5% | -$393.7K |
| M | 2023-03-10 | 2023-03-08 | KYNB | Chung Christine | SVP, China Ops | A - Grant | $0.00 | +15.1K | 257.3K | +6% | $0 |
| M | 2023-03-10 | 2023-03-08+ | KYNB | Chung Christine | SVP, China Ops | S - Sale | $20.70 | -16.0K | 262.0K | -6% | -$330.4K |
| M | 2023-03-10 | 2023-03-08+ | KYNB | Wettig Thane | Chief Commercial Off | S - Sale | $20.63 | -13.9K | 116.3K | -11% | -$287.5K |
| M | 2023-03-10 | 2023-03-08 | KYNB | Wettig Thane | Chief Commercial Off | A - Grant | $0.00 | +15.1K | 119.2K | +15% | $0 |
| M | 2023-03-10 | 2023-03-08 | KYNB | Conterno Enrique A | CEO, Dir | A - Grant | $0.00 | +60.3K | 379.2K | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations